[go: up one dir, main page]

PE20080106A1 - Composicion farmaceutica estable de carisoprodol y meloxicam - Google Patents

Composicion farmaceutica estable de carisoprodol y meloxicam

Info

Publication number
PE20080106A1
PE20080106A1 PE2007000064A PE2007000064A PE20080106A1 PE 20080106 A1 PE20080106 A1 PE 20080106A1 PE 2007000064 A PE2007000064 A PE 2007000064A PE 2007000064 A PE2007000064 A PE 2007000064A PE 20080106 A1 PE20080106 A1 PE 20080106A1
Authority
PE
Peru
Prior art keywords
carisoprodol
pharmaceutical composition
meloxicam
stable pharmaceutical
sprains
Prior art date
Application number
PE2007000064A
Other languages
English (en)
Inventor
Regalado Antonio Santiago
Leon Sixto Serafin Espinoza
Original Assignee
Silanes Sa De Cv Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37897453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080106(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Silanes Sa De Cv Lab filed Critical Silanes Sa De Cv Lab
Publication of PE20080106A1 publication Critical patent/PE20080106A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE MELOXICAM EN UNA CANTIDAD EQUIVALENTE DE 7,5-15 mg Y CARISOPRODOL EN UNA CANTIDAD EQUIVALENTE DE 200-600 mg. DICHA COMPOSICION ES SEGURA PARA LA ADMINISTRACION DE CORTO TIEMPO (15 DIAS), NO PROVOCA DANO INTESTINAL SIENDO UTILES EN EL TRATAMIENTO DE DOLORES MUSCULARES O ESQUELETICOS TALES COMO TORTICOLIS, TORCEDURAS, ESGUINCES, LUXACIONES, DISTENSIONES MUSCULARES, TENDINOSAS Y LIGAMENTOSAS, DOLOR POST-TRAUMATICO, FRACTURAS Y DEMAS PROCESOS RELACIONADOS CON INFLAMACION Y CONTRACTURA
PE2007000064A 2006-01-20 2007-01-19 Composicion farmaceutica estable de carisoprodol y meloxicam PE20080106A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA06000760A MXPA06000760A (es) 2006-01-20 2006-01-20 Composicion farmaceutica estable de carisoprodol y meloxicam.

Publications (1)

Publication Number Publication Date
PE20080106A1 true PE20080106A1 (es) 2008-04-27

Family

ID=37897453

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000064A PE20080106A1 (es) 2006-01-20 2007-01-19 Composicion farmaceutica estable de carisoprodol y meloxicam

Country Status (7)

Country Link
US (1) US20070213324A1 (es)
EP (1) EP1810674A1 (es)
AR (1) AR059081A1 (es)
CO (1) CO5940095A1 (es)
GT (1) GT200700005A (es)
MX (1) MXPA06000760A (es)
PE (1) PE20080106A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1103205A2 (pt) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda Composição farmacêutica oral e uso da composição farmacêutica oral
MX393662B (es) * 2018-11-05 2025-03-24 Federico Amezcua Amezcua Composición farmacéutica que comprende la combinación de un inhibidor selectivo de la ciclooxigenasa 2 y un carbamato derivado de la guaifenesina para el tratamiento del dolor, inflamación y contractura muscular.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
US20040204413A1 (en) 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AR059081A1 (es) 2008-03-12
GT200700005A (es) 2007-08-28
US20070213324A1 (en) 2007-09-13
EP1810674A1 (en) 2007-07-25
MXPA06000760A (es) 2007-07-19
CO5940095A1 (es) 2008-07-31

Similar Documents

Publication Publication Date Title
UY23992A1 (es) Procedimiento para la preparación de compuestos de 1-fenil-3-dimetilamino-propano
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
SV2011003901A (es) Compuestos de arilo con sustituyentes heterocíclicos como inhibidores de hif
DOP2009000155A (es) Derivados de hetero-pentaciclo-fenilo fusionados, composicion farmaceutica que los comprende y usos para preparar un medicamento util para el tratamiento de una condicion mediada por p38
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
AR047928A1 (es) Derivados de tetrahidropiridoindol
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
PE20170302A1 (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington
AR040032A1 (es) C-aril-glucosidos como inhibidores de sglt2 y metodo
AR022076A1 (es) Composicion antioxidante constituida por acetil l-carnitina y acido alfa-lipoico para mejorar el aprovechamiento metabolico de la glucosa
CL2008002052A1 (es) Compuestos derivados de pirazol, inhibidores de la 11 beta-hidroxi-esteroide-deshidrogenasa; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y uso para la preparacion de medicamentos para el tratamiento de diabetes, obesidad, trastornos de ingestion de comida o dislipidemia
CR10167A (es) "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor"
DOP2006000057A (es) Composición farmaceútica para el tratamiento del cáncer
CL2008002984A1 (es) Composicion farmaceutica que comprende micofenolato sodico y su uso para el tratamiento y/o prevencion en enfermedades autoinmunes tales como el rechazo de aloinjertos o xenoinjertos de organos, celulas o tejidos y como antiinflamatorio.
AR109263A2 (es) Composición que comprende moxidectina
CO5590913A2 (es) Terapia de combinacion antivirica
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
GB2456475A (en) Composition for the treatment of skin conditions
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
ES2149279T3 (es) Sistema terapeutico para el tratamiento de la psoriasis.
RU2011148355A (ru) Применение аллопуринола для ладонно-родошвенного синдрома
PE20080106A1 (es) Composicion farmaceutica estable de carisoprodol y meloxicam
AR083095A1 (es) Cocristal de aprepitant l-prolina y composicion farmaceutica
AR045263A1 (es) Metodo, kit y composicion farmaceutica para tratar infecciones virales

Legal Events

Date Code Title Description
FC Refusal